Quest Diagnostics (DGX) Cash & Equivalents Growth (1y) (2010 - 2026)
Quest Diagnostics (DGX) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 47.04% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 19.65% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 21.60% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -6.38% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 12.96% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 11.35% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | -16.86% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 96.24% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 165.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.24% |
| Mar 31, 2026 | 109.04% |
| Dec 31, 2025 | -23.50% |
| Sep 30, 2025 | -43.46% |
| Jun 30, 2025 | 17.71% |
| Mar 31, 2025 | -60.34% |
| Dec 31, 2024 | -19.97% |
| Sep 30, 2024 | 434.27% |
| Jun 30, 2024 | 115.08% |
| Mar 31, 2024 | 170.86% |
| Dec 31, 2023 | 117.78% |
| Sep 30, 2023 | -79.57% |
| Jun 30, 2023 | -84.05% |
| Mar 31, 2023 | -75.42% |
| Dec 31, 2022 | -63.88% |
| Sep 30, 2022 | -29.08% |
| Jun 30, 2022 | 41.07% |
| Mar 31, 2022 | -42.11% |
| Dec 31, 2021 | -24.70% |
| Sep 30, 2021 | -38.50% |